Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125785171 | 12578517 | 1 | I | 20160714 | 20160721 | 20160721 | EXP | GB-MHRA-ADR 23556586 | GB-ACCORD-042549 | ACCORD | 74.00 | YR | M | Y | 0.00000 | 20160721 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125785171 | 12578517 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | STARTED ON MAY 2016 FROM 250 MG THEN DOSE INCREASED TO 500 MG THEN 750 MG | U | 90843 | BID | |||||||||
125785171 | 12578517 | 2 | C | COLECALCIFEROL | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
125785171 | 12578517 | 3 | C | ASPIRIN. | ASPIRIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125785171 | 12578517 | 1 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125785171 | 12578517 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125785171 | 12578517 | Condition aggravated | |
125785171 | 12578517 | Dysuria | |
125785171 | 12578517 | Skin discolouration |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125785171 | 12578517 | 1 | 201605 | 0 |